Edwin Posadas, MD

Dr. O'Donnell specializes in the treatment of patients with genitourinary malignancies(bladder, prostate, kidney and testicular cancers) with a focus on bladder cancer.

Dr. O'Donnell's clinical focus is on achieving individualized care by considering each patient's genetic profile when making therapeutic decisions, specifically chemotherapy choices.

Dr. O'Donnell has advanced training in pharmacology and pharmacogenomics (the study of genetic causes of inter-patient differences in drug response or toxicity), and is a well-published researcher.

Dr. O'Donnell also serves as Principal Investigator of "The 1200 Patients Project," a new initiative within the Center for Personalized Therapeutics at The University of Chicago. He is leading initiatives to explore the feasibility and utility of incorporating broad pharmacogenomic testing into routine clinical practice.

Dr. O'Donnell attended medical school and did his residency and fellowship at the University of Chicago.